Maze Therapeutics Inc (MAZE)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Atul DandekarChief Strategy & Business Officer | -7.50k | 119.40k | Derivative Exercise and Sale | 10.42 - 26.34 | 24.81k | - |
| 2026-05-22 | Dr. Jason V. ColomaCEO & Director | -32.56k | 847.05k | Automatic Disposition | 26.00 - 26.02 | 379.51k | -7.90% |
| 2026-05-15 | Dr. Jason V. ColomaCEO & Director | -1.94k | 50.39k | Automatic Disposition | 26.00 | 412.07k | -0.47% |
| 2026-05-14 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15.00k | 237.05k | Derivative Exercise and Sale | 10.42 - 26.22 | - | - |
| 2026-05-04 | Mr. Atul DandekarChief Strategy & Business Officer | 14.31k | 149.06k | Derivative Exercise and Retained Stock | 10.42 | 24.81k | 136.20% |
| 2026-05-04 | Dr. Charles J. HomcyDirector | -7.42k | 0.00 | Other Disposition | - | 31.11k | -19.26% |
| 2026-04-29 | Mr. Atul DandekarChief Strategy & Business Officer | -7.50k | 112.15k | Derivative Exercise and Sale | 10.42 - 25.37 | 10.50k | - |
| 2026-04-01 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15.00k | 285.60k | Derivative Exercise and Sale | 10.42 - 31.07 | 0.00 | - |
| 2026-04-01 | Ms. Amy Bachrodtインサイダー | -2.50k | 47.56k | Derivative Exercise and Sale | 10.42 - 30.34 | 12.97k | - |
| 2026-03-30 | Mr. Atul DandekarChief Strategy & Business Officer | -7.50k | 141.87k | Derivative Exercise and Sale | 10.42 - 30.02 | 10.50k | - |
| 2026-03-20 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15.00k | 580.14k | Derivative Exercise and Sale | 10.42 - 50.02 | 0.00 | - |
| 2026-03-10 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -30.00k | 1.20M | Derivative Exercise and Sale | 10.42 - 51.02 | 0.00 | - |
| 2026-02-27 | Mr. Atul DandekarChief Strategy & Business Officer | -7.50k | 262.57k | Derivative Exercise and Sale | 10.42 - 45.72 | 10.50k | - |
| 2026-03-02 | Ms. Amy Bachrodtインサイダー | -5.00k | 173.91k | Derivative Exercise and Sale | 10.42 - 45.47 | 12.97k | - |
| 2026-02-02 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15.00k | 534.03k | Derivative Exercise and Sale | 10.42 - 47.23 | - | - |
| 2026-02-02 | Ms. Amy Bachrodtインサイダー | -5.00k | 178.12k | Derivative Exercise and Sale | 10.42 - 46.63 | 12.97k | - |
| 2026-01-29 | Mr. Atul DandekarChief Strategy & Business Officer | -7.50k | 253.84k | Derivative Exercise and Sale | 10.42 - 45.01 | 10.50k | - |
| 2026-01-22 | Ms. Amy Bachrodtインサイダー | -5.00k | 175.51k | Derivative Exercise and Sale | 10.42 - 45.52 | 12.97k | - |
| 2026-01-07 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -25.16k | 749.17k | Derivative Exercise and Sale | 10.42 - 40.20 | 0.00 | - |
| 2026-01-06 | Dr. Catherine Angell SohnIndependent Non-Employee Director | -29.41k | 842.57k | Derivative Exercise and Sale | 10.42 - 39.11 | 0.00 | - |
| 2026-01-02 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -4.84k | 145.19k | Derivative Exercise and Sale | 10.42 - 40.43 | 0.00 | - |
| 2026-01-02 | Ms. Amy Bachrodtインサイダー | -5.00k | 143.65k | Derivative Exercise and Sale | 10.42 - 39.57 | 12.97k | - |
| 2025-12-29 | Mr. Atul DandekarChief Strategy & Business Officer | -72.50k | 2.19M | Derivative Exercise and Sale | 10.42 - 41.13 | 10.50k | - |
| 2025-12-29 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -45.00k | 1.36M | Derivative Exercise and Sale | 10.42 - 40.93 | - | - |
| 2025-12-29 | Ms. Amy Bachrodtインサイダー | -15.00k | 449.87k | Derivative Exercise and Sale | 10.42 - 41.16 | 12.97k | - |
| 2025-11-04 | Third Rock Ventures, LLC法人 | -1.60M | 0.00 | Other Disposition | - | 5.42M | -22.78% |
| 2025-10-23 | Dr. Charles J. HomcyDirector | -28.42k | 0.00 | Other Disposition | - | 37.05k | -43.41% |
| 2025-09-15 | Dr. Richard H. SchellerIndependent Non-Employee Director | -20.74k | 464.03k | 売り | 22.37 | 0.00 | -100.00% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。